---
title: "匯盈控股供股獲 9.86% 認購  集資 2,195 萬元"
description: "匯盈控股公佈供股結果，接獲涉及合共 4,878.49 萬股有效接納及申請，相當於發售總數的 9.86%。集資總額 2,195 萬元。餘下 4.45 億股未獲認購股份，將按照協議配售。"
type: "news"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/261765564.md"
published_at: "2025-10-19T09:46:52.000Z"
---

# 匯盈控股供股獲 9.86% 認購  集資 2,195 萬元

> 匯盈控股公佈供股結果，接獲涉及合共 4,878.49 萬股有效接納及申請，相當於發售總數的 9.86%。集資總額 2,195 萬元。餘下 4.45 億股未獲認購股份，將按照協議配售。

匯盈控股 (00821.HK) 公佈供股結果，接獲涉及合共 4,878.49 萬股有效接納及申請，相當於發售總數的 9.86%。集資總額 2,195 萬元。餘下 4.45 億股未獲認購股份，將按照協議配售。

### Related Stocks

- [02169.HK - 滄港鐵路](https://longbridge.com/zh-HK/quote/02169.HK.md)
- [02909.HK - SH GROWTH RTS](https://longbridge.com/zh-HK/quote/02909.HK.md)
- [00821.HK - 匯盈控股](https://longbridge.com/zh-HK/quote/00821.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Value Convergence Holdings Grants 24.7 Million Share Options to Directors and Employees | Value Convergence Holdings Ltd. has granted 24.7 million share options to eligible participants, including directors and | [Link](https://longbridge.com/zh-HK/news/273687511.md) |
| Retal Urban Development Signs SSA With Alfozan Holding For Ajdan Co Shares | Retal Urban Development Company SJSC :RETAL URBAN DEVELOPMENT - SIGNS SHARE SWAP AGREEMENT WITH ALFOZAN HOLDING FOR AJDA | [Link](https://longbridge.com/zh-HK/news/275995528.md) |
| Contel Technology Announces Charge Of Shares Of The Controlling Shareholder | Contel Technology Co Ltd :CEO LAM KEUNG CHARGES SHARES OF P.GRAND IN FAVOUR OF CHARGEE AS SECURITY FOR A LOAN FACILITYP. | [Link](https://longbridge.com/zh-HK/news/275835556.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/zh-HK/news/276051793.md) |
| CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | CSPC Pharmaceutical Receives Regulatory Nods to Begin Drug Trials | [Link](https://longbridge.com/zh-HK/news/276035104.md) |

---

> **免責聲明**：本文內容僅供參考，不構成任何投資建議。